Nephrology

SLE

Questions discussed in this category

Do you hospitalize patients with newly diagnosed lupus nephritis and nephrotic syndrome if you are able to provide pulse steroids outpatient and follow them closely?

When do you decide to hospitalize?

1 Answer available

Would you feel comfortable adding benlysta to patient already taking both mycophenolate and tacrolimus (and hydroxychloroquine) who still has some evidence of active lupus nephritis?

3 Answers available

Is there a role for eculizumab in the management of refractory lupus nephritis?

3 Answers available

Papers discussed in this category

Rheumatology international, 2017 Mar 03

Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence.

Rheumatology (Oxford, England), 2015 Aug 27

Eculizumab as rescue therapy in severe resistant lupus nephritis.

Arthritis and rheumatism, 2011-12

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.

N Engl J Med,

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.

Lupus,

Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis.

Arthritis Rheumatol, 2017 Apr 07

Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study.

Lancet (London, England), 2011 Feb 04

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.

Related Topics in Nephrology